Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in haemodialysis patients and staff

European Journal of Epidemiology

Volumn 17, Issue 2, 2001, Pages 145-149

  Teles, S A ^a,b   Martins, R M B ^a   Lopes, C L R ^a   Dos Santos Carneiro, M A ^a   Souza, K P ^a   Yoshida, C F T ^b  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Haemodialysis; Hepatitis B; Recombinant hepatitis B vaccine

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGE; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; BODY MASS; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; DOSE RESPONSE; DRUG INDUCED DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HEMODIALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; MALE; VACCINATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; BRAZIL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNOGENETICS; MALE; MIDDLE AGED; RENAL DIALYSIS; VACCINES, SYNTHETIC;

EID: 0034811956     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017918218784     Document Type: Article

References (29)

1. Over a decade of experience with a yeast recombinant hepatitis B vaccine
2. Hepatitis virus infection in haemodialysis patients from Moldavia
3. Recombinant hepatitis B vaccine use in chronic haemodialysis patients: Long-term evaluation and cost-effectiveness analysis
4. Hepatitis B virus infection profile in Central Brazilian haemodialysis population
5. National surveillance of dialysis associated diseases in the United States, 1995
6. Outbreaks of hepatitis B virus infection among haemodialysis patients - California, Nebraska, and Texas
7. Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff
8. Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin
9. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through Universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP)
10. Hepatitis B vaccine in haemodialysis patients with hepatitis C viral infection
11. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in haemodialysis patients
12. Antibody Response to heat-inactivated hepatitis B vaccine (CLB-3 μg) in haemodialysis patients and occupational risk personnel: A one year follow-up
13. Status of hepatitis B immunization programmes in 1998
14. Efficacy of a recombinant hepatitis B vaccine (Euvax-B) in adult patients awaiting liver transplantation: Preliminary results
15. Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis B vaccination in maintenance haemodialysis patients
16. Immunogenicity of the recombinant GenHevac B Pasteur vaccine against hepatitis B in chronic uremic patients
17. Successful vaccination with intradermal hepatitis B vaccine in haemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine
18. Reponse to the hepatitis B virus vaccine in haemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality
19. Immune response after vaccination with recombinant hepatitis surface antigen in maintenance haemodialysis patients and healthy controls
20. Immune response to a recombinant hepatitis B vaccine in haemodialysis patients
21. Hepatitis B vaccines in patients with chronic renal failure before dialysis
22. Immunogenicity of hepatitis B vaccines: Implications for persons at occupational risk of hepatitis B virus infection
23. Vacinação contra hepatite B - Oito anos de experiência
24. Age-related hepatitis B seroconversion rates in health care workers
25. Hepatitis B vaccination program at a New York City hospital: Seroprevalence, seroconversion, and declination
26. Host defenses and immunologic alterations associated with chronic haemodialysis
27. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene
28. Geographic distribution of HBsAg subtypes in Brazil
29. Hepatitis B virus: Genotypes and subtypes in Brazilian haemodialysis patients